Related Experiment Video
Updated: Sep 26, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
Epstein-Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish
Manuela Horndasch1, Eva E Raschke, Guido Bommer
1Institute of Clinical Molecular Biology and Tumor Genetics, GSF-Research Center for Environment and Health, Munich, Germany.
Abstract:
TGF-beta induces apoptosis and inhibits the proliferation of EBV-negative B-lymphoma cell lines. In contrast, EBV-immortalized B cells are resistant to both the proapoptotic and the antiproliferative activities of TGF-beta. We have generated a lymphoblastoid cell line, in which we can switch on and off the EBV-specific transcriptional program driven by EBNA2. When these cells express the EBNA2-driven phenotype, they are resistant to TGF-beta-mediated growth arrest. We used this cell line to readdress the question of how EBV can overcome the antiproliferative TGF-beta activity. We show here that EBV-driven cells remain TGF-beta-responsive since TGF-beta target genes are readily induced. Thus, EBV can overcome TGF-beta-mediated growth arrest without interfering with the core machinery of the TGF-beta signaling pathway, which links ligand binding to the induction of TGF-beta target genes.
Insights
Epstein-Barr virus (EBV) confers resistance to TGF-beta
Area of Science:
- Molecular Biology
- Virology
- Immunology
Background:
- Transforming growth factor-beta (TGF-beta) typically induces apoptosis and inhibits proliferation in B-lymphoma cells.
- Epstein-Barr virus (EBV) immortalization confers resistance to TGF-beta's antiproliferative and proapoptotic effects in B cells.
Purpose of the Study:
- To investigate the mechanism by which EBV overcomes TGF-beta-mediated growth arrest in B cells.
- To determine if EBV interferes with the core TGF-beta signaling pathway.
Main Methods:
- Generation of a lymphoblastoid cell line with an inducible EBV-specific transcriptional program (driven by EBNA2).
- Assessment of TGF-beta responsiveness and target gene induction in EBV-expressing versus EBV-negative cells.
Main Results:
- EBV-immortalized cells expressing the EBNA2-driven phenotype are resistant to TGF-beta-induced growth arrest.
- EBV-driven cells remain responsive to TGF-beta, as evidenced by the induction of TGF-beta target genes.
- EBV overcomes TGF-beta's antiproliferative activity without disrupting the core TGF-beta signaling pathway.
Conclusions:
- EBV confers resistance to TGF-beta-mediated growth arrest in B cells.
- This resistance is achieved without interfering with the fundamental TGF-beta signaling cascade.
- EBV's mechanism of overcoming TGF-beta antiproliferative effects lies downstream of target gene induction.
Related Concept Videos
Negative Regulator Molecules
Mitogens and the Cell Cycle
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway

